Qube Research & Technologies (QRT)’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
Other funds holding NTLA
Qube Research & Technologies (QRT)'s NTLA Position: Q3 2026 in Review
Qube Research & Technologies (QRT) opened a new position in Intellia Therapeutics (NTLA) in Q3 2026: 10,640 shares worth $128K. The stake represents ﹤0.01% of the portfolio and ranks #3222 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in NTLA as recently as Q4 2025.
Qube Research & Technologies (QRT) first reported a position in NTLA in Q2 2021 and has held it in 14 quarters since. The position peaked at $7.34M in Q4 2023. 312 funds tracked by Wall St. Rank hold NTLA as of Q3 2026.
- Qube Research & Technologies (QRT) held 10,640 shares of Intellia Therapeutics worth $128K as of Q3 2026.
- Intellia Therapeutics was a new Qube Research & Technologies (QRT) position in Q3 2026.
- Intellia Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #3222 holding.
- Qube Research & Technologies (QRT) first reported a position in Intellia Therapeutics in Q2 2021 and has held it in 14 quarters since.
- Qube Research & Technologies (QRT)'s Intellia Therapeutics position peaked at $7.34M in Q4 2023.
- 312 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q3 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.